Jiangsu Nhwa Pharmaceutical Co., LTD reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 992.59 million compared to CNY 904.07 million a year ago. Revenue was CNY 992.59 million compared to CNY 904.07 million a year ago. Net income was CNY 188.69 million compared to CNY 167.79 million a year ago. Basic earnings per share from continuing operations was CNY 0.19 compared to CNY 0.17 a year ago. Diluted earnings per share from continuing operations was CNY 0.19 compared to CNY 0.17 a year ago.